The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease.

The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease.

http://www.wikidata.org/entity/Q35841731

about

Brain fuel metabolism, aging, and Alzheimer's disease Heart failure and Alzheimer's disease Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease Protective effects of low-intensity pulsed ultrasound on aluminum-induced cerebral damage in Alzheimer's disease rat model.Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations.Neuropathology in the adult changes in thought study: a review.The use of recently developed histochemical markers for localizing neurotoxicant induced regional brain pathologies.Blood-based biomarkers of microvascular pathology in Alzheimer's disease.Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice.'Alzheimer-like' pathology in a murine model of arterial hypertension.Brain aging in the oldest-old.Protection after stroke: cellular effectors of neurovascular unit integrity.Role of vascular risk factors and vascular dysfunction in Alzheimer's disease.Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells CARDIOVASCULAR RISK FACTORS AFFECT HIPPOCAMPAL MICROVASCULATURE IN EARLY AD.Mitral and tufted cells are potential cellular targets of nitration in the olfactory bulb of aged mice.Dexamethasone diminishes the pro-inflammatory and cytotoxic effects of amyloid beta-protein in cerebrovascular smooth muscle cells.Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein.Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease The role of environmental exposures in neurodegeneration and neurodegenerative diseases.Pepsin pretreatment allows collagen IV immunostaining of blood vessels in adult mouse brain.Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid beta-protein precursor transgenic mice Brain and behavioral perturbations in rats following Western diet access.Glio-vascular changes during ageing in wild-type and Alzheimer's disease-like APP/PS1 mice.Cerebral microvascular rather than parenchymal amyloid-β protein pathology promotes early cognitive impairment in transgenic mice Correlation of CT perfusion and CT volumetry in patients with Alzheimer's disease.Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease.Is the ischemic blood-brain barrier insufficiency responsible for full-blown Alzheimer's disease?Pathology and pathogenesis of vascular cognitive impairment-a critical update Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer's disease.The bradykinin B1 receptor regulates Aβ deposition and neuroinflammation in Tg-SwDI mice.New therapeutic targets in the neurovascular pathway in Alzheimer's disease.Brain ischemia and ischemic blood-brain barrier as etiological factors in sporadic Alzheimer's disease Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views.Altered expression of claudin family proteins in Alzheimer's disease and vascular dementia brains.Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies Novel cerebrovascular pathology in mice fed a high cholesterol diet.

P2860

Q24625859-DD0D5ABE-D6D6-4234-B1AD-4C61A344D143 Q26852526-1702C781-73CC-473D-9ECA-B85CFD02F012 Q28586383-503D0F6D-7684-4907-87A7-1E446333E735 Q30413664-FE687BE6-B714-44EA-9C38-8F22F8AA90BA Q33556372-F8457EDD-6A6C-453C-B38F-6CDEAFBB8000 Q33561657-A1A609AB-87B5-4EA1-B58E-4C6E7DF45E57 Q33584889-54EEE39F-76DB-4D0F-B4E9-E1F323880715 Q33625663-6F60A615-D859-42A8-89F0-A4B16BAB5B39 Q33782706-C1A3B0EB-E432-4E93-8EF5-0D48F0917DF9 Q33793048-CDADC79C-0AD4-4D89-BD1D-523010C5F864 Q33970434-CE984991-814F-4154-92F0-D27C97C4EDCD Q34034151-018808F1-00F3-4AFA-94CB-2E723D26AEA0 Q34043168-2CCA291B-5A6E-43E0-B4B2-E7206DA7F7FA Q34055011-82514171-764E-486C-A855-95870665B375 Q34094501-E83704CE-246C-4819-9D8E-7158D5CCAC1A Q34575537-28F7C36B-C245-4FBE-A8E2-FB06F89B185B Q34635421-08493700-BB06-449B-9534-AFFF89BD77DA Q35013183-9E3BB09B-9ADB-4C06-BCD7-3A60B2EEFB1B Q35085102-E978A12A-26A9-442F-BC6D-A7F27105BF40 Q35141182-E7D47E05-584E-4BAD-8640-1BAF923D03A5 Q35551001-6837313B-55F4-4285-87E3-85BDFE24A57F Q35910824-8D955F88-68EB-4F7D-AAD7-EE1FA472FA4D Q35942285-E17EDB7F-1DF2-49AE-9DC9-55E762006762 Q35988455-91B71AD3-A941-4955-B615-81CC32D2C6D1 Q35995420-A9361EF3-D053-4B3B-9A59-D9DF3734A9CE Q36051548-1FA3D555-0EB1-4B39-9169-C6D76EDB0546 Q36076645-4569F24F-5FCB-4FC2-AA2D-D038835E1697 Q36136387-3376FBEB-6596-46C0-8D33-ED0C30D5DB0C Q36330297-B6297AA5-4C66-4E60-9EA7-9A9CFB9F235D Q36404535-3EAEF7E6-5425-473E-AC14-2CFBD8DCEFBD Q36582789-15429929-B513-4C02-B9DD-DAA432233B81 Q36754568-25C2B7C5-70C3-4A28-9913-F913CA259A38 Q36782606-E6EB81C4-01DF-4653-9AB8-721FA5D56F38 Q36817597-E739C993-AE2D-4314-8807-A2754D65CC1C Q36876341-4A9549BC-B8C8-4CEB-BFD2-622A2F289710 Q37062573-8E9B76CA-6323-433A-8C68-73B77E69C05F Q37266151-6AD317E9-38A8-4940-AA26-683B283EB867 Q37294353-9D91F13C-C6EF-44EF-B4A3-AC2D7BF5F07C Q37308961-A76AB7ED-5F44-4AED-8A01-37E1AEABE230 Q37414216-F81AB091-03F4-4E0B-93C5-A2A34BF7B63D

P2860

The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease.

http://www.wikidata.org/entity/Q35841731

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

The nature and effects of cort ...... aging and Alzheimer's disease.

@ast

The nature and effects of cort ...... aging and Alzheimer's disease.

@en

type

label

The nature and effects of cort ...... aging and Alzheimer's disease.

@ast

The nature and effects of cort ...... aging and Alzheimer's disease.

@en

prefLabel

The nature and effects of cort ...... aging and Alzheimer's disease.

@ast

The nature and effects of cort ...... aging and Alzheimer's disease.

@en

P1433

Q35841731-D869C011-AA22-427E-AC01-F528DF6332A3

P1476

Q35841731-9EB2D2F8-50C5-45EA-B13A-A5BA449A555B

P2093

Q35841731-12301674-4CDF-4D9B-901A-6BE61BA23032

Q35841731-3D452097-31E3-470F-8848-ECBDA6230812

Q35841731-680B8C95-581A-4B4C-885E-8F0DA17EFA9C

Q35841731-E49F4315-3BD2-48F9-9039-9EC0819E0C30

P2860

Q35841731-00354FBE-99CC-4511-9F77-5DD23ED64CC4

Q35841731-0936170E-D46D-4128-9C75-3288C75B5384

Q35841731-0DB5189D-E621-459B-8DAF-108CB4815CBC

Q35841731-121E0A24-A32A-4220-BA3C-5A8C2D227C2B

Q35841731-15D54EED-3C50-483C-B85C-86BA0021AC0F

Q35841731-1A186C87-BA09-46B7-B841-93899187E965

Q35841731-1F4AA819-6DB2-4D00-8A8D-4FCBD2C65AAE

Q35841731-203B6A41-EDF4-4499-BE85-C1AF854D5FA4

Q35841731-25F35902-C706-49C5-86DE-FC23C290E90A

Q35841731-261C7C2F-D0C5-44A5-B08E-6F7A4BD0DF2F

P304

Q35841731-AC446E6A-8DE1-49AD-85D0-9E5609622B1B

P31

Q35841731-54B5D85D-25E4-41C5-9E68-F5417EB95AA5

P356

Q35841731-19AA8F91-9603-42E3-8918-F182563E9431

P433

Q35841731-B04FD09D-84BF-4821-90E2-A6AD7BFD4E36

P478

Q35841731-4AE73F3D-3443-4D89-A19D-EC3EEB04D4A7

P577

Q35841731-561685AB-624E-4F3A-8DB0-CE52B52F1906

P698

Q35841731-F574968A-6E39-4F2E-820B-5E67BEC280D3

P921

Q35841731-3485BB4A-B73C-4BA4-922A-3E169F7EBF21

P356

016164104225016272

P1433

Neurological Research

P1476

The nature and effects of cort ...... aging and Alzheimer's disease.

@en

P2093

Anne B Rocher

http://www.w3.org/2001/XMLSchema#string

Claire B Rivara

http://www.w3.org/2001/XMLSchema#string

Patrick R Hof

http://www.w3.org/2001/XMLSchema#string

Thomasina L Bailey

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropathological stageing of Alzheimer-related changes

Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism

Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature.

Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease.

Do experienced diagnosticians agree about the diagnosis of dementia from survey data? The effects of informants' reports and interviewers' vignettes.

Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation.

Vascular factors in cognitive impairment--where are we now?

Alzheimer's disease and vascular dementia. Some points of confluence.

Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease.

Dietary fat intake and the risk of incident dementia in the Rotterdam Study.

P304

573-578

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1179/016164104225016272

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15265277

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease